Geri Dön

Regulation and role of Brn-2 in control of Mitf expression

Başlık çevirisi mevcut değil.

  1. Tez No: 400881
  2. Yazar: EDA SÜER
  3. Danışmanlar: PROF. COLIN GODING
  4. Tez Türü: Doktora
  5. Konular: Biyokimya, Biochemistry
  6. Anahtar Kelimeler: Belirtilmemiş.
  7. Yıl: 2011
  8. Dil: İngilizce
  9. Üniversite: Unıversıty Of London
  10. Enstitü: Yurtdışı Enstitü
  11. Ana Bilim Dalı: Belirtilmemiş.
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: Belirtilmemiş.

Özet

Özet yok.

Özet (Çeviri)

One of the key issues in cancer is how signal transduction pathways regulate the transcriptional program that defines a cell's identity. In melanocytes and melanoma the Microphthalmia-associated transcription factor (Mitf) is required for melanocyte/melanoma survival, proliferation and migration/metastasis. Intermediate levels of Mitf activity promote proliferation, elevated levels of Mitf activity leads to differentiation associated with G1 arrest and high levels of p21 and p16, whereas low levels of Mitf activity leads to a p27-dependent G1 arrest and invasiveness. Understanding how Mitf expression is controlled is therefore a key issue. The Brn-2 (POU3F2) transcription factor belongs to the POU domain eukaryotic transcriptional factor family that plays a major role in development. Brn-2 is poorly expressed in melanocytes in culture, but is expressed at higher levels in melanomas. Intriguingly, Brn-2 can both activate and repress the Mitf promoter, but how Brn-2 activity is controlled is not known. We show here that the capacity of Brn-2 to activate or repress is dependent on both the target promoter and its post-translational modification. The results suggest that Alanine substitutions at phosphorylation sites at the N-terminus lead to localisation of Brn-2 to heterochromatin and failure to be phosphorylated by p38 SAPK. On the other hand, Glutamic acid substitutions lead to localisation of Brn-2 to euchromatin and enhance phosphorylation by p38 SAPK. Brn-2 is also regulated during the cell cycle. Brn-2 levels are elevated in G2 and decrease in mitosis, suggesting that Brn-2's ability to bind DNA is regulated by a mitotic kinase. In addition, we also employed a kinase inhibitor library to identify small molecule regulators of Mitf expression and found a variety of compounds that alter Mitf expression substantially. Collectively, the results indicate that regulation of Brn-2 activity may be a critical determinant of Mitf expression and consequently melanoma behaviour.

Benzer Tezler

  1. Kömür yakılan kazanda ve sobada ağır metal emisyonlarının incelenmesi

    Başlık çevirisi yok

    EMEL SAÇAKLI

    Yüksek Lisans

    Türkçe

    Türkçe

    1998

    Kimya Mühendisliğiİstanbul Teknik Üniversitesi

    Kimya Mühendisliği Ana Bilim Dalı

    PROF. DR. HASANCAN OKUTAN

  2. Çoklu amaçların çözümlemesinde amaç programlaması ile genelleştirilmiş ters yaklaşımı ve yem sanayiinde bir uygulama

    Goal programming and generalieed inverse approaches in the multi-objective analysis and application in feed industry

    HASAN BAL

    Doktora

    Türkçe

    Türkçe

    1986

    İstatistikGazi Üniversitesi

    İstatistik Ana Bilim Dalı

    DOÇ. DR. FEVZİ KUTAY

  3. Mimarlıkta rasyonel ve irrasyonel biçimlendirmenin ekonomik göstergelere bağlı olarak değişimi ve bu değişimin 11. yüzyıldan 19. yüzyıla kadar Türk ve Avrupa uygarlıklarında örneklenmesi

    The Change of rational and irrational styles in architecture duetotho economicaldata and the illustration of this change on the Turkish and European Civilizations between 11th and 19th centuries

    AYŞE ZEYNEP ONUR

    Doktora

    Türkçe

    Türkçe

    1986

    MimarlıkGazi Üniversitesi

    Mimarlık Ana Bilim Dalı

    DOÇ. DR. UMUR ERKMAN

  4. Kan basıncı değişiminin böbrek dokusunda gösterdiği histolojik farklılaşmalar

    Renal tissue alternations caused by a change in the blood pressure

    BİLGE ONARLIOĞLU(TÖREL)

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    1987

    MorfolojiCumhuriyet Üniversitesi

    Morfoloji Ana Bilim Dalı

    DOÇ. DR. ERDOĞAN GÜRSOY